Lv3
220 积分 2025-09-23 加入
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
4个月前
已完结
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
8个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
8个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
8个月前
已完结
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics
10个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
10个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
11个月前
已完结
皖公网安备34019202002308
